News | January 26, 2024
Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Inducts advanced AI-Powered 24x7 remote patient monitoring system
He is also inducted as a member of the management council and senior management personnel of the company
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Sirius JV will be owned 51% by Sirius and 49% by Adani
Furthering cell therapy ambition across oncology and autoimmune diseases
The plant is yet to start commercial operations
Receives registration of Valganciclovir powder for oral solution in Germany
Subscribe To Our Newsletter & Stay Updated
